Analysis

  • Migraine: is gammaCore the solution?

    Successful migraine treatments still elude the medical industry despite the World Health Organisation classifying chronic migraine as more disabling than blindness, paraplegia, angina or rheumatoid arthritis. US-based company electroCore claims...

  • August’s top news stories

    The US FDA approved the first generic version of the EpiPen to treat allergic reactions in emergency cases, and an international team of researchers discovered a blood biomarker to help...